Recall of several batches of Combiwave 250,25 µg/ Pressurised inhalation product
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Combiwave 250,25 µg/ Pressurised inhalation Fluticasone Propionate, Salmeterol 1202256882 12250193B 12250232A 12250233A 12250332A 12250339A 12240471 12240771 12240772 12241372A Glenmark...
التصنيف
ملف
التاريخ
2025-10-20
اسم المستحضر
Combiwave 250,25 µg
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The Saudi Food and Drug Authority (SFDA) has issued a recall of several batches of the product Combiwave 250,25 µg/ Pressurised inhalation due to the batches’ non-compliance with the approved specifications of the product.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.